Class IIDrug
Clindamycin Palmitate Hydrochloride for Oral Solution recall
Summary
Heritage Pharmaceuticals Inc is recalling CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION (drug). According to the FDA report, the reason is: Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles. The FDA rated this a Class II: the product may cause temporary or medically reversible health problems; serious harm is unlikely. Recall status: Ongoing.
Details from the FDA report
- Product
- CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51
- Reason
- Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
- Lot / code info
- Lot #: 2411550, Exp. 2026/NOV.
- Quantity
- Not listed
- Distribution
- Nationwide within the U.S
- Recalling company
- Heritage Pharmaceuticals Inc, East Brunswick, NJ United States
- Recall started
- July 30, 2026
- FDA report date
- August 19, 2026
- Classification
- Class II: The product may cause temporary or medically reversible health problems; serious harm is unlikely.
- Voluntary / mandated
- Voluntary: Firm initiated
- Status
- Ongoing
- Recall number
- D-0768-2026
What to do
- Check whether you have this product, and compare the lot numbers, codes, or dates on your package with the codes listed above.
- If it matches, stop using it and keep it away from children and pets.
- Contact the recalling company (Heritage Pharmaceuticals Inc) or the store where you bought it about returns or refunds.
- Do not stop a prescribed medication without first talking to your pharmacist or doctor; they can help find a safe replacement.
- If you think the product made you or someone else sick, contact a doctor or pharmacist. In an emergency call 911.
- You can report problems to the FDA via MedWatch.